Iterum Therapeutics' Cash, Cash Equivalents And Short-term Investments Were $18.2 Million At March 31, 2024 Will Be Sufficient To Fund Its Operations Into 2025
Iterum Therapeutics' Cash, Cash Equivalents And Short-term Investments Were $18.2 Million At March 31, 2024 Will Be Sufficient To Fund Its Operations Into 2025
截至2024年3月31日，Iterum Therapeutics的現金、現金等價物和短期投資爲1,820萬美元，將足以爲其2025年的運營提供資金
Iterum Therapeutics' Cash, Cash Equivalents And Short-term Investments Were $18.2 Million At March 31, 2024 Will Be Sufficient To Fund Its Operations Into 2025
截至2024年3月31日，Iterum Therapeutics的現金、現金等價物和短期投資爲1,820萬美元，將足以爲其2025年的運營提供資金
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。